BioVie Enters Sales Agreement With Alliance Global Partners For Up To $6,464,341 Of Stock

On September 11, 2026, BioVie Inc., a Nevada corporation (the "Company"), entered into a sales agreement (the "Sales Agreement") with A.G.P./Alliance Global Partners (the "Agent"), pursuant to which the Company may issue and sell from time to time, to or through the Agent, shares of the Company’s Class A common stock, par value $0.0001 per share ("Common Stock"), having an aggregate offering price of up to $6,464,341 (the "Placement Shares").

The Placement Shares will be offered and sold pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-296924) (the "Registration Statement"), which was filed with the Securities and Exchange Commission ("SEC") on June 18, 2026 and declared effective by the SEC on June 29, 2026, the base prospectus contained therein, and a prospectus supplement that was filed with the SEC on September 11, 2026.

The Agent may sell the Placement Shares by any method deemed to be an "at-the-market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), including, without limitation, sales made directly on or through The Nasdaq Capital Market or on any other existing trading market in the United States for the Common Stock. The Agent may also sell Placement Shares in negotiated transactions with the Company’s prior approval. The Agent will use commercially reasonable efforts to sell on the Company’s behalf all the Placement Shares requested to be sold by the Company, consistent with the Company’s normal trading and sales practices, on mutually agreed terms.

The Sales Agreement contains customary representations, warranties and agreements by the Company and indemnification obligations of the Company and the Agent for certain liabilities under the Securities Act. Under the terms of the Sales Agreement, the Company will pay the Agent a commission equal to 3.0% of the gross proceeds of the Placement Shares sold through the Agent under the Sales Agreement. In addition, the Company has agreed to reimburse the Agent for certain specified expenses.

The Company intends to use the proceeds from the sale of the Placement Shares, if any, for general corporate purposes.